Julora Health ®
Tirzepatide
Dual GIP / GLP-1 receptor agonist research material.
$60.00
A single-component research material supplied for controlled research environments. Tirzepatide is a dual-agonist analog targeting both GIP and GLP-1 receptors, suitable for comparative studies of incretin co-activation, energy balance modeling, lipid metabolism characterization, and receptor signaling assays in model systems.
Appearance
Lyophilized white powder in a sealed 3 mL research vial
Lyophilized white powder in a sealed 3 mL research vial
Reconstitution
Reconstitute with 2 mL of BAC Water. Gently swirl after reconstitution — do not shake.
Reconstitute with 2 mL of BAC Water. Gently swirl after reconstitution — do not shake.
Purity: 99.9%
Third-party tested via HPLC & Mass Spec
Fast Shipping
Ships within 1–2 business days
Research Use Only
Not for human consumption
Lot-Specific COA
Available on request
Research Focus (non-clinical)
Research Focus (non-clinical)
Research Focus (non-clinical)
⚠️ Important Notice: This product is intended for research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
